PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,069 | -30.1% | 188,664 | 0.0% | 0.04% | -47.2% |
| Q2 2023 | $450,907 | -22.9% | 188,664 | 0.0% | 0.07% | -45.9% |
| Q1 2023 | $584,859 | +15.7% | 188,664 | 0.0% | 0.13% | +9.0% |
| Q4 2022 | $505,619 | -9.4% | 188,664 | 0.0% | 0.12% | +9.9% |
| Q3 2022 | $558,000 | -26.2% | 188,664 | -26.8% | 0.11% | -19.6% |
| Q2 2022 | $756,000 | -50.1% | 257,853 | -13.0% | 0.14% | -30.7% |
| Q1 2022 | $1,515,000 | -19.6% | 296,426 | +6.1% | 0.20% | -29.2% |
| Q4 2021 | $1,885,000 | -43.2% | 279,256 | -41.8% | 0.28% | +20.1% |
| Q3 2021 | $3,321,000 | -41.7% | 479,995 | -17.9% | 0.23% | -49.1% |
| Q2 2021 | $5,696,000 | -44.3% | 584,804 | -10.0% | 0.46% | +33.7% |
| Q1 2021 | $10,223,000 | -35.0% | 649,542 | 0.0% | 0.34% | -50.4% |
| Q4 2020 | $15,725,000 | +29.3% | 649,542 | -10.1% | 0.69% | -21.2% |
| Q3 2020 | $12,158,000 | -21.5% | 722,443 | +36.8% | 0.88% | -28.6% |
| Q2 2020 | $15,480,000 | – | 527,964 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |